Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Stroke, ischaemic
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Andrew A. Wong, James P. Davis, Philip J. Schluter, Robert D. Henderson, John D. O’Sullivan, Stephen J. Read
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (2007) 24 (1): 104–110.
Published Online: 23 May 2007
... to in the content or advertisements. Stroke, ischaemic Temperature over time Mixed-effects models The relevant hospital and university medical research ethics committees approved the study. Informed consent was obtained from the participant or their next of kin when the participant was unable...
Journal Articles
Journal:
Cerebrovascular Diseases
Cerebrovasc Dis (2000) 10 (2): 147–150.
Published Online: 18 February 2000
... to in the content or advertisements. Stroke, ischaemic Secondary prevention Trial Patients who have had a transient ischaemic attack (TIA) or stroke of presumed arterial origin have an annual risk of serious vascular complications that ranges between 4 and 11% without treatment [ 1, 2 ]. Aspirin...
